Bard Avault Pelvic Support System Lawsuit MDL Hearing Set for Sept 30

A panel of federal judges will hear oral arguments next week about whether to consolidate a growing number of lawsuits over the Bard Avaulta Pelvic Support System, which have been filed by individuals who suffered severe permanent injury and disfiguration due to alleged design defects with the vaginal surgical mesh. 

The U.S. Judicial Panel on Multidistrict Litigation is scheduled to meet on September 30 in Nashville, Tennessee, at which time they will consider whether 36 Bard Avaulta lawsuits pending in four different federal district courts should be centralized for pretrial proceedings before one judge as part of a multidistrict litigation, or MDL.

A growing number of lawsuits over Bard Avaulta vaginal mesh have been filed in courts throughout the United States involving similar allegations that C.R. Bard, the manufacturer, was negligent in the product’s design and in failing to warn patients of possible complications with Bard Avaulta pelvic organ prolapse mesh.

Learn More About

Vaginal Mesh Lawsuits

Complications from transvaginal mesh may cause severe injuries.

Learn More About this Lawsuit SEE IF YOU QUALIFY FOR COMPENSATION

In July, a petition was filed with the U.S. Judicial Panel on Multidistrict Litigation to consolidate the federal Bard Avaulta litigation in one court for pretrial proceedings. The petition seeks to have the cases consolidated in either the Southern District of West Virginia or the Northern District of Georgia.

In October 2008, the FDA issued a warning about problems with surgical mesh like the Bard Avaulta. The vaginal mesh products, which are used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI), have been associated with hundreds of reports of severe infection, pain, urinary problems and bowel, bladder or blood-vessel perforations. Many women have also reported recurrences of the prolapse or incontinence, and the need for additional surgeries to remove mesh that had eroded into the vagina.

A pelvic organ prolapse occurs when organs such as the bladder, uterus, bowel or rectum drop and push against the wall of the vagina. This happens when the muscles holding the pelvic organ in place become weak or stretched, often due to childbirth or surgery. The surgical mesh is used to support the muscle.

If an MDL, or multidistrict litigation, is formed, all cases filed in federal district courts throughout the United States will be transferred to one judge. In addition, as Bard Avaulta vaginal mesh lawyers continue to review and file additional federal cases in the future, those claims will also be transferred into the MDL.

2 Comments

  • RebeccaJuly 2, 2011 at 3:25 pm

    I had a total vaginal hysterectomy and arc bladder sling in 2009. Today, I suffer intermittent episodes of bladder pain as well as difficulty with bowel movements, which I did not have before. I will be researching the arc sling type as recovery from the bladder surgery was way more awful than getting over the hysterectomy.

  • tamyJanuary 15, 2011 at 4:24 am

    OMG this totally describes me and my problems i have had sience my surgery for prolapse utterus and recticille in sept. 2oo7. i dont know what they used , but i bet you i will find out !

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Gardasil Lawsuits Over Failure To Warn Doctors About HPV Vaccine Risks Cleared To Move Forward
Gardasil Lawsuits Over Failure To Warn Doctors About HPV Vaccine Risks Cleared To Move Forward (Posted today)

A federal judge has cleared Gardasil lawsuits to move forward, after paring down plaintiffs' claims to those alleging Merck either failed to warn, or fraudulently concealed, the HPV vaccine's risks from the medical community.